Disposition kinetics of propranolol isomers in the perfused rat liver

被引:10
作者
Hung, DY [1 ]
Siebert, GA [1 ]
Chang, P [1 ]
Anissimov, YG [1 ]
Roberts, MS [1 ]
机构
[1] Univ Queensland, Princess Alexandra Hosp, Dept Med, Woolloongabba, Qld 4102, Australia
关键词
D O I
10.1124/jpet.104.070011
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The aim of this study was to define the determinants of the linear hepatic disposition kinetics of propranolol optical isomers using a perfused rat liver. Monensin was used to abolish the lysosomal proton gradient to allow an estimation of propranolol ion trapping by hepatic acidic vesicles. In vitro studies were used for independent estimates of microsomal binding and intrinsic clearance. Hepatic extraction and mean transit time were determined from outflow-concentration profiles using a nonparametric method. Kinetic parameters were derived from a physiologically based pharmacokinetic model. Modeling showed an approximate 34-fold decrease in ion trapping following monensin treatment. The observed model-derived ion trapping was similar to estimated theoretical values. No differences in ion-trapping values was found between R(+)- and S(-)- propranolol. Hepatic propranolol extraction was sensitive to changes in liver perfusate flow, permeability-surface area product, and intrinsic clearance. Ion trapping, microsomal and nonspecific binding, and distribution of unbound propranolol accounted for 47.4, 47.1, and 5.5% of the sequestration of propranolol in the liver, respectively. It is concluded that the physiologically more active S(-)- propranolol differs from the R(+)- isomer in higher permeability-surface area product, intrinsic clearance, and intracellular binding site values.
引用
收藏
页码:822 / 829
页数:8
相关论文
共 31 条
[1]
ANDERSON JH, 1978, J PHARMACOL EXP THER, V206, P172
[2]
BAI SA, 1983, J PHARMACOL EXP THER, V227, P360
[3]
LACK OF INTER-ACTION BETWEEN PROPRANOLOL AND MEBANAZINE [J].
BARRETT, AM ;
CULLUM, VA .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1968, 20 (12) :911-&
[4]
An optimized model for rat liver perfusion studies [J].
Cheung, K ;
Hickman, PE ;
Potter, JM ;
Walker, NI ;
Jericho, M ;
Haslam, R ;
Roberts, MS .
JOURNAL OF SURGICAL RESEARCH, 1996, 66 (01) :81-89
[5]
Mechanisms of cellular distribution of psychotropic, drugs. Significance for drug action and interactions [J].
Daniel, WA .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2003, 27 (01) :65-73
[6]
THE EFFECT OF HYPOXIA AND ACIDOSIS ON PROPRANOLOL CLEARANCE IN THE ISOLATED PERFUSED-RAT-LIVER PREPARATION [J].
ELLIOTT, SL ;
MORGAN, DJ ;
ANGUS, PW ;
GHABRIAL, H ;
SMALLWOOD, RA .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (03) :763-765
[7]
GOLDSTEIN A, 1974, BASIS PHARM, P227
[8]
Cationic drug pharmacokinetics in diseased livers determined by fibrosis index, hepatic protein content, microsomal activity, and nature of drug [J].
Hung, DY ;
Chang, P ;
Cheung, K ;
McWhinney, B ;
Masci, PP ;
Weiss, M ;
Roberts, MS .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (03) :1079-1087
[9]
Hung DY, 2001, J PHARMACOL EXP THER, V297, P780
[10]
ENZYMATIC BASIS FOR THE NONLINEARITY OF HEPATIC ELIMINATION OF PROPRANOLOL IN THE ISOLATED PERFUSED-RAT-LIVER [J].
ISHIDA, R ;
SUZUKI, K ;
MASUBUCHI, Y ;
NARIMATSU, S ;
FUJITA, S ;
SUZUKI, T .
BIOCHEMICAL PHARMACOLOGY, 1992, 44 (12) :2281-2288